Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Interest Coverage Ratio (2021 - 2025)

Historic Interest Coverage Ratio for Fennec Pharmaceuticals (FENC) over the last 10 years, with Q3 2025 value amounting to 0.32.

  • Fennec Pharmaceuticals' Interest Coverage Ratio rose 9364.5% to 0.32 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.7, marking a year-over-year decrease of 50634.96%. This contributed to the annual value of 0.63 for FY2024, which is 11677.24% up from last year.
  • Fennec Pharmaceuticals' Interest Coverage Ratio amounted to 0.32 in Q3 2025, which was up 9364.5% from 4.6 recorded in Q2 2025.
  • In the past 5 years, Fennec Pharmaceuticals' Interest Coverage Ratio registered a high of 13.29 during Q1 2024, and its lowest value of 1230.75 during Q1 2021.
  • For the 5-year period, Fennec Pharmaceuticals' Interest Coverage Ratio averaged around 110.41, with its median value being 5.37 (2023).
  • The largest annual percentage gain for Fennec Pharmaceuticals' Interest Coverage Ratio in the last 5 years was 30125.81% (2024), contrasted with its biggest fall of 32716.86% (2024).
  • Fennec Pharmaceuticals' Interest Coverage Ratio (Quarter) stood at 75.87 in 2021, then skyrocketed by 86.2% to 10.47 in 2022, then soared by 81.03% to 1.99 in 2023, then surged by 51.34% to 0.97 in 2024, then soared by 66.64% to 0.32 in 2025.
  • Its last three reported values are 0.32 in Q3 2025, 4.6 for Q2 2025, and 1.36 during Q1 2025.